Combination procedure offers many advantages

Article

The combination of sutureless coaxial microincision cataract surgery and 23-gauge vitrectomy confers many advantages, including less wound leakage, good anterior chamber stability, safety, decreased inflammation and faster rehabilitation after surgery, according to the authors of a study published recently in Retina: The Journal of Retinal and Vitreous Diseases.

The combination of sutureless coaxial microincision cataract surgery and 23-gauge vitrectomy confers many advantages, including less wound leakage, good anterior chamber stability, safety, decreased inflammation and faster rehabilitation after surgery, according to the authors of a study published recently in Retina: The Journal of Retinal and Vitreous Diseases.

For this retrospective review, researchers from Linköping University Hospital, Linköping, Sweden, and St Erik Eye Hospital, Stockholm, reviewed outcomes and findings in 50 patients (50 eyes) who underwent coaxial microincision cataract surgery and foldable IOL implantation, combined with 23- gauge vitrectomy for a variety of indications between January 2010 and March 2012. They reviewed the indications, intraoperative/ postoperative complications and outcomes.

Their data showed the following:

  • No posterior capsule tears were seen during surgery.
  • Retinal breaks were found intraoperatively in nine eyes (18%), which were then successfully treated with laser and/or cryotherapy.
  • Corneal suture was done in six eyes (12%).
  • Sclerotomy was sutured in two left and two right eyes (total: 8%).
  • In one case, a 23-gauge vitrectomy was converted to a 20-gauge vitrectomy.

Mean postoperative intraocular pressures (IOP) were 16.7 mmHg, and hypotony, defined as an IOP > 9 mmHg) occurred in nine eyes (18%). Posterior iris synechiae were seen 2 weeks postoperatively, with an IOP of > 40 mmHg in one eye (2%), and was normalized after Nd:YAG laser iridotomy.

Fibrin reaction in the anterior chamber was seen in one eye (2%) on day 1 posteroperatively. Finally, posterior capsule opacification requiring Nd:YAG laser capsulotomy was seen in 11 eyes (22%) during follow up.

Further information on this study can be found by clicking here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.